Cache Advisors’s Roivant Sciences ROIV Stock Holding History

Cache Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.1M	Buy	+538,600	New	+$15.9M	1.62%	13

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cache Advisors's ROIV Position: Q2 2026 in Review

Cache Advisors opened a new position in Roivant Sciences (ROIV) in Q2 2026: 538,600 shares worth $19.1M. The stake represents 1.62% of the portfolio and ranks #13 among its holdings.

499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Cache Advisors held 538,600 shares of Roivant Sciences worth $19.1M as of Q2 2026.
Roivant Sciences was a new Cache Advisors position in Q2 2026.
Roivant Sciences made up 1.62% of Cache Advisors's portfolio in Q2 2026, its #13 holding.
499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Cache Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.